Predicting treatment failure in patients with community acquired pneumonia: A case-control study

Respiratory Research

Volumn 15, Issue 1, 2014, Pages

  Martin Loeches, Ignacio ^a   Valles, Xavier ^b   Menendez, Rosario ^c   Sibila, Oriol ^d   Montull, Beatriz ^c   Cilloniz, Catia ^a   Artigas, Antonio ^a   Torres, Antoni ^b  

^a HOSPITAL DE SABADELL   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c HOSPITAL UNIVERSITARIO LA FE   (Spain)

^d HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

Community acquired pneumonia; Cytokines; Pneumonia; Treatment failure

Indexed keywords

C REACTIVE PROTEIN; CEPHALOSPORIN; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; MACROLIDE; PROCALCITONIN; QUINOLONE; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE; IL6 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; COMMUNITY ACQUIRED PNEUMONIA; COMORBIDITY; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HOSPITALIZATION; HUMAN; LOWER RESPIRATORY TRACT INFECTION; LUNG INFILTRATE; MAJOR CLINICAL STUDY; MALE; PLEURA EFFUSION; SEPTIC SHOCK; TREATMENT FAILURE; BLOOD SAMPLING; COMPARATIVE STUDY; CYTOKINE PRODUCTION; FOLLOW UP; MIDDLE AGED; PREDICTION; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; BLOOD; COMMUNITY-ACQUIRED INFECTIONS; PLEURAL EFFUSION; PNEUMONIA; PREDICTIVE VALUE; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; COMMUNITY-ACQUIRED INFECTIONS; CYTOKINES; FEMALE; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED; PLEURAL EFFUSION; PNEUMONIA; PREDICTIVE VALUE OF TESTS; TREATMENT FAILURE; YOUNG ADULT;

EID: 84925050187     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-15-75     Document Type: Article

References (19)

1. Menéndez R, Sahuquillo-Arce JM, Reyes S, Martínez R, Polverino E, Cillóniz C, Córdoba JG, Montull B, Torres A. Cytokine activation patterns and biomarkers are influenced by microorganisms in community-acquired pneumonia. Chest 2012, 141:1537-45.
2. Garcia-Vidal C, Carratalà J. Early and late treatment failure in community-acquired pneumonia. Semin Respir Crit Care Med 2009, 30:154-60.
3. Ramírez P, Ferrer M, Martí V, Reyes S, Martínez R, Menéndez R, Ewig S, Torres A. Inflammatory biomarkers and prediction for intensive care unit admission in severe community-acquired pneumonia. Crit Care Med 2011, 39:2211-7.
4. Boomer JS, To K, Chang KC, Takasu O, Osborne DF, Walton AH, Bricker TL, Jarman SD, Kreisel D, Krupnick AS, Srivastava A, Swanson PE, Green JM, Hotchkiss RS. Immunosuppression in patients who die of sepsis and multiple organ failure. JAMA 2011, 306:2594-605.
5. Yende S, D'Angelo G, Kellum JA, Weissfeld L, Fine J, Welch RD, Kong L, Carter M, Angus DC. Inflammatory markers at hospital discharge predict subsequent mortality after pneumonia and sepsis. Am J Respir Crit Care Med 2008, 177:1242-7.
6. Bloos F, Marshall JC, Dellinger RP, Vincent J-L, Gutierrez G, Rivers E, Balk RA, Laterre P-F, Angus DC, Reinhart K, Brunkhorst FM. Multinational, observational study of procalcitonin in ICU patients with pneumonia requiring mechanical ventilation: a multicenter observational study. Crit Care 2011, 15:R88.
7. Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC, Dowell SF, File TM, Musher DM, Niederman MS, Torres A, Whitney CG. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007, 44 Suppl 2(Suppl 2):S27-S72.
8. Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weissfeld LA, Singer DE, Coley CM, Marrie TJ, Kapoor WN. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997, 336:243-50.
9. Arancibia F, Ewig S, Martinez JA, Ruiz M, Bauer T, Marcos MA, Mensa J, Torres A. Antimicrobial treatment failures in patients with community-acquired pneumonia: causes and prognostic implications. Am J Respir Crit Care Med 2000, 162:154-60.
10. Menéndez R, Torres A, Zalacaín R, Aspa J, Martín Villasclaras JJ, Borderías L, Benítez Moya JM, Ruiz-Manzano J, Rodríguez de Castro F, Blanquer J, Pérez D, Puzo C, Sánchez Gascón F, Gallardo J, Alvarez C, Molinos L. Risk factors of treatment failure in community acquired pneumonia: implications for disease outcome. Thorax 2004, 59:960-5.
11. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent J-L, Ramsay G. SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med 2001, 2003(29):530-8.
12. Biesheuvel CJ, Vergouwe Y, Steyerberg EW, Grobbee DE, Moons KGM. Polytomous logistic regression analysis could be applied more often in diagnostic research. J Clin Epidemiol 2008, 61:125-34.
13. Rodriguez A, Lisboa T, Blot S, Martin-Loeches I, Solé-Violan J, De Mendoza D, Rello J. Mortality in ICU patients with bacterial community-acquired pneumonia: when antibiotics are not enough. Intensive Care Med 2009, 35:430-8.
14. Eklund CM. Proinflammatory cytokines in CRP baseline regulation. Adv Clin Chem 2009, 48:111-36.
15. Coelho LM, Salluh JIF, Soares M, Bozza FA, Verdeal JCR, Castro-Faria-Neto HC, Silva JR LE, Bozza PT, Póvoa P. Patterns of c-reactive protein RATIO response in severe community-acquired pneumonia: a cohort study. Crit Care 2012, 16:R53.
16. Kishimoto T. IL-6: from its discovery to clinical applications. Int Immunol 2010, 22:347-52.
17. Radtke S, Wüller S, Yang X, Lippok BE, Mütze B, Mais C, de Leur HS-V, Bode JG, Gaestel M, Heinrich PC, Behrmann I, Schaper F, Hermanns HM. Cross-regulation of cytokine signalling: pro-inflammatory cytokines restrict IL-6 signalling through receptor internalisation and degradation. J Cell Sci 2010, 123(Pt 6):947-59.
18. Garcia-Vidal C, Fernández-Sabé N, Carratalà J, Díaz V, Verdaguer R, Dorca J, Manresa F, Gudiol F. Early mortality in patients with community-acquired pneumonia: causes and risk factors. Eur Respir J 2008, 32:733-9.
19. Talbot GH, Powers JH, Fleming TR, Siuciak JA, Bradley J, Boucher H. Progress on developing endpoints for registrational clinical trials of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections: update from the Biomarkers Consortium of the Foundation for the National Institutes of He. Clin Infect Dis 2012, 55:1114-21.